Almac has completed expansion of refrigerated (2-8°C) storage and labelling facilities at its UK site.
This enhancement doubles Almac’s refrigerated storage capacity in the UK and comes as a response to a growing number of client requests involving Biologics, Biosimilar Compounds and other temperature critical material.
According to the company, the labelling and distribution of cold chain materials can often prove complicated given the temperature sensitive nature of the products.
In most cases, the product has a limited amount of time that it can be out of the specified temperature, whether it be 2-8°C or colder.
With the introduction of the refrigerated labelling facility and expansion of refrigerated storage, Almac is able to offer a more streamlined cold chain service by ensuring the material flow is consistently monitored at every stage in the clinical supply chain.
The offering, mirrored at the company’s US headquarters in Souderton, PA, is a substantial benefit to existing and potential clients where maintaining temperature control is critical to the shelf life and stability of their compound or the chosen comparator.
